Skip to main content

Table 2 Demographic and clinical characteristics of patients with HM and patients with HM and IM

From: Characterizing patients with rare mucormycosis infections using real-world data

 

Overall HM cohort

N = 962,428

HM and IM cohort

N = 1133

n

(%)

n

(%)

Age group

 0–12

68,892

7.16

40

3.53

 13–17

23,548

2.45

13

1.15

 18–39

139,684

14.51

139

12.27

 40–64

374,517

38.91

601

53.05

 65+

355,453

36.93

340

30.01

Sex

 Female

542,919

56.41

644

56.84

 Male

418,637

43.50

489

43.16

Race

 African American

100,958

10.49

84

7.41

 Asian

15,613

1.62

14

1.24

 Caucasian

757,088

78.66

968

85.44

 Other/unknown

88,769

9.22

67

5.91

Ethnicity

 Hispanic

40,235

4.18

52

4.59

 Non-Hispanic

826,907

85.92

1035

91.35

 Unknown

95,286

9.90

46

4.06

US region

 Midwest

505,791

52.55

951

83.94

 Northeast

129,764

13.48

38

3.35

 South

203,603

21.16

90

7.94

 West

92,147

9.57

40

3.53

 Other/unknown

31,123

3.23

14

1.24

Clinical forms of IM

 Pulmonary mucormycosis

45

3.97

 Rhinocerebral mucormycosis

35

3.09

 Gastrointestinal mucormycosis

0

0.00

 Cutaneous mucormycosis

29

2.56

 Disseminated mucormycosis

12

1.06

 Mucormycosis, unspecified

109

9.62

 Other zygomycoses

8

0.71

 Zygomycosis, unspecified

54

4.77

  1. HM hematologic malignancy, IM invasive mucormycosis, N the total number of patients, n number of patients in the category